> More than twice as many patients _with diabetes_ exposed to GLP-1 RAs developed nAMD compared to those in a matched cohort of similar patients who were unexposed.
Emphasis mine, but it's important context that probably wouldn't fit in the title.
Emphasis mine, but it's important context that probably wouldn't fit in the title.